Cargando…
Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients
We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The v...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674661/ https://www.ncbi.nlm.nih.gov/pubmed/33251247 http://dx.doi.org/10.3389/fmolb.2020.575483 |
_version_ | 1783611551845974016 |
---|---|
author | Tang, Xingxing Cao, Yudong Liu, Jia Wang, Shuo Yang, Yong Du, Peng |
author_facet | Tang, Xingxing Cao, Yudong Liu, Jia Wang, Shuo Yang, Yong Du, Peng |
author_sort | Tang, Xingxing |
collection | PubMed |
description | We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The values of Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet to Lymphocyte Ratio (PLR), Lymphocyte to Monocyte Ratio (LMR), Systemic Immune-inflammation Index (SII), and Prognostic Nutritional Index (PNI) were calculated by blood routine test results before operation. After obtaining the postoperative pathology of the patients, the Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves was calculated to evaluate the diagnostic value of these IFs in pathology and their corresponding cut-off values. A total of 641 bladder cancer patients were enrolled. The median values of NLR, dNLR, PLR, LMR, SII, and PNI were 6.33, 4.09, 156.47, 2.66, 1114.29, and 51.45, respectively. Grouped patients according to the pathological grade, the NLR, dNLR, PLR, and SII of the high-grade group were significantly higher than those of the low-grade group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while the LMR and PNI were significantly lower than those of the low-grade group (P = 0.003 and P < 0.001). Divided patients into non-muscle invasion group (Tis + Ta + T1) and muscle invasion group (T2 + T3 + T4), in which NLR, dNLR, PLR, and SII in the muscle invasion group were significantly higher than those in the non-muscle invasion group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while LMR and PNI were significantly lower than those in the low-grade group (P = 0.012 and P < 0.001). ROC curves analyses showed that NLR, dNLR, PLR, LMR, SII, and PNI had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively) and muscle invasion (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively). The results suggest the higher NLR, dNLR, PLR, SII, and lower LMR and PNI are associated with higher risk of high-grade and muscle invasive disease. However, this conclusion needs to be further clarified in the future. |
format | Online Article Text |
id | pubmed-7674661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76746612020-11-27 Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients Tang, Xingxing Cao, Yudong Liu, Jia Wang, Shuo Yang, Yong Du, Peng Front Mol Biosci Molecular Biosciences We conducted this study to evaluate the diagnostic value of Inflammatory Factors (IFs) in the pathology of bladder cancer patients. The patients who were diagnosed with urothelial bladder carcinoma (bladder cancer) and underwent surgical treatment in our center from 2014 to 2019 were enrolled. The values of Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet to Lymphocyte Ratio (PLR), Lymphocyte to Monocyte Ratio (LMR), Systemic Immune-inflammation Index (SII), and Prognostic Nutritional Index (PNI) were calculated by blood routine test results before operation. After obtaining the postoperative pathology of the patients, the Area Under Curve (AUC) of Receiver Operating Characteristic (ROC) curves was calculated to evaluate the diagnostic value of these IFs in pathology and their corresponding cut-off values. A total of 641 bladder cancer patients were enrolled. The median values of NLR, dNLR, PLR, LMR, SII, and PNI were 6.33, 4.09, 156.47, 2.66, 1114.29, and 51.45, respectively. Grouped patients according to the pathological grade, the NLR, dNLR, PLR, and SII of the high-grade group were significantly higher than those of the low-grade group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while the LMR and PNI were significantly lower than those of the low-grade group (P = 0.003 and P < 0.001). Divided patients into non-muscle invasion group (Tis + Ta + T1) and muscle invasion group (T2 + T3 + T4), in which NLR, dNLR, PLR, and SII in the muscle invasion group were significantly higher than those in the non-muscle invasion group (P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), while LMR and PNI were significantly lower than those in the low-grade group (P = 0.012 and P < 0.001). ROC curves analyses showed that NLR, dNLR, PLR, LMR, SII, and PNI had predictive value for pathological grade (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively) and muscle invasion (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively). The results suggest the higher NLR, dNLR, PLR, SII, and lower LMR and PNI are associated with higher risk of high-grade and muscle invasive disease. However, this conclusion needs to be further clarified in the future. Frontiers Media S.A. 2020-11-05 /pmc/articles/PMC7674661/ /pubmed/33251247 http://dx.doi.org/10.3389/fmolb.2020.575483 Text en Copyright © 2020 Tang, Cao, Liu, Wang, Yang and Du. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Tang, Xingxing Cao, Yudong Liu, Jia Wang, Shuo Yang, Yong Du, Peng Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title | Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title_full | Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title_fullStr | Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title_full_unstemmed | Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title_short | Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients |
title_sort | diagnostic value of inflammatory factors in pathology of bladder cancer patients |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674661/ https://www.ncbi.nlm.nih.gov/pubmed/33251247 http://dx.doi.org/10.3389/fmolb.2020.575483 |
work_keys_str_mv | AT tangxingxing diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients AT caoyudong diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients AT liujia diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients AT wangshuo diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients AT yangyong diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients AT dupeng diagnosticvalueofinflammatoryfactorsinpathologyofbladdercancerpatients |